Global Interventional Oncology Market is Driven by Rise in the Volume of Patients Suffering From Breast, Liver, Lung and Other Cancer.

Interventional Oncology Market is estimated to grow at a CAGR of 6.89% for 2021 to 2028 with factors such as, rising number of applications from emerging economies along with increasing number of hospitals which are creating opportunities in the market in the above mentioned forecasted period.

However, lack of skilled and well-trained radiologists and oncologists along with unfavourable regulations of the government are some of the vital factors restraining the market growth.

Interventional oncology market has shown an exceptional penetration in developed economies in North America due to growing number of technological advancement in the healthcare sector in the region.

Interventional Oncology Market Scenario

According to Data Bridge Market Research interventional oncology market is witnessing a significant growth in developed economies during the forecast period of 2021-2028 due to factors such as, increasing preferences towards the minimally invasive procedures, increasing prevalence of geriatric and target population, growing levels of public-private funding and government support for interventional oncology, and increasing number of technological advancements.

Now the question is which are the other regions interventional oncology market is targeting? Data Bridge Market Research has estimated a large growth in Asia-Pacific interventional oncology market. The Data bridge market research new reports highlight the major growth factors and opportunities in the interventional oncology market.

For more analysis on the interventional oncology market request for a briefing with our analysts.

Scope of the Interventional Oncology Market Scenario

Interventional oncology market is segmented on the basis of countries U.S., Canada and Mexico in North America,  Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

  • All country based analysis of interventional oncology market is further analyzed based on maximum granularity into further segmentation. Based on product, the interventional oncology market is segmented into embolization devices, ablation devices, and support devices. Interventional oncology market has also been segmented based on the end user into hospital, ambulatory care centres, and research and academia. Based on procedure, the interventional oncology market is segmented into thermal tumour ablation, non-thermal tumour ablation, transcatheter arterial chemoembolization, transcatheter arterial radioembolization/selective internal radiation therapy, transcatheter arterial embolization/bland embolization. On the basis of application, the interventional oncology market is segmented into liver cancer, lung cancer, breast cancer, prostate cancer, kidney cancer, bone metastasis, and others.
  • Interventional oncology deals with the diagnosis and treatment of cancer using techniques that are minimally invasive and conducted under image guidance. Interventional oncology is used to treat almost all sorts of cancer known to human kind.

To know more about the study

Key Pointers Covered in Interventional Oncology Market and Forecast to 2028

  • Market Size
  •  Market New Sales Volumes
  •  Market Replacement Sales Volumes
  • Market Installed Base
  •  Market By Brands
  •  Market Procedure Volumes
  •  Market Product Price Analysis
  •  Market Healthcare Outcomes
  • Market Cost of Care Analysis
  • Market Regulatory Framework and Changes
  • Market Prices and Reimbursement Analysis
  •  Market Shares in Different Regions
  •  Recent Developments for Market Competitors
  •  Market Upcoming Applications
  •  Market Innovators Study

Key Market Competitors Covered in the report

  • HealthTronics, Inc.
  • Trod Medical
  • Sanarus
  • Teleflex Incorporated
  • MedWaves, Inc.
  • IceCure Medical Ltd
  • Terumo Europe NV
  • Medtronic
  • Boston Scientific Corporation
  • Johnson & Johnson Services, Inc.
  • Merit Medical Systems
  • AngioDynamics
  • Cook
  • BD
  • Profound Medical
  • Sirtex SIR-Spheres Pty Ltd
  • Accuray Incorporated
  • Siemens Healthcare GmbH

Above are the key players covered in the report, to know about more and exhaustive list of interventional oncology market companies, contact us.

 Research Methodology: Interventional Oncology Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Related Reports

Browse in Healthcare Category Related Reports@